Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Xếp hạng trong cổ phiếu #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Giá cổ phiếu
$63.48
Đồng bộ lần cuối: 2024-12-17
Vốn hóa thị trường
$11.52B
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch Catalent, Inc. (CTLT)

Danh mục

Giá của CTLT với vốn hóa thị trường của B
Catalent, Inc. Catalent, Inc.
CTLT
$63.48
Vốn hóa thị trường của Catalent, Inc.(CTLT)
Vốn hóa thị trường: $11.52B
Tính đến năm August 2026, Catalent, Inc. có vốn hóa thị trường là $11.52B. Theo dữ liệu của chúng tôi, điều này khiến Catalent, Inc. trở thành công ty có giá trị lớn thứ 1926th trên thế giới theo vốn hóa thị trường. Vốn hóa thị trường là tổng giá trị thị trường của tất cả cổ phiếu đang lưu hành của một công ty niêm yết và thường được sử dụng để đo lường giá trị của công ty đó.
Lịch sử vốn hóa thị trường của Catalent, Inc. từ 2014 đến 2026
CTLT So với Top 5 phổ biến nhất stocks
Giá của CTLT Tài sản B Thị trường của B Kết quả
Catalent, Inc. Catalent, Inc.
$27,838.96 $11.52B
$5.053T +43,754.70%
Catalent, Inc. Catalent, Inc.
$25,146.49 $11.52B
$4.564T +39,513.25%
Catalent, Inc. Catalent, Inc.
$23,114.19 $11.52B
$4.196T +36,311.77%
Catalent, Inc. Catalent, Inc.
$19,993.66 $11.52B
$3.629T +31,396.00%
Catalent, Inc. Catalent, Inc.
$15,543.14 $11.52B
$2.821T +24,385.09%